MEDS (TRxADE Health Corp) Company Total Asset Base

MEDS (TRxADE HEALTH Inc) - company brandmark

TRxADE HEALTH, Inc. (MEDS) is developing a cloud-based B2B service for wholesale pharmaceutical procurement by US pharmacies, aiming to expand its influence within the med-IT sector. As reflected in the pakistan chart, the asset value on GURU.Markets is 43.49, and while the business possesses defensive qualities, a recession could limit client spending on digitalization. Stable partner trust provides the company with a moderately positive image as a reliable operator.

trxadehealth.com (MEDS) - Cumulative Company Assets from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for TRxADE (MEDS)

- current quotes and average value forecast:
Market Chart trxadehealth.com|MEDS - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization TRxADE Health Corp|MEDS - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Price of a Share TRxADE HEALTH|MEDS - Company Net Assets|Market Value to Book Value trxadehealth.com|MEDS - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio TRxADE HEALTH, Inc.|MEDS - Long-Term Debt to Capital|Current Liabilities to Capital TRxADE Health Corp|MEDS - Company Aggregate Debts|Debt to Book Value Ratio TRxADE Health Corp|MEDS - Company Long-Term Liabilities|Amount of Current Liabilities TRxADE HEALTH|Intermediate Coverage Ratio trxadehealth.com
- earnings and valuation multiples indicators:
MEDS - Net Income
Fundamental valuation:trxadehealth.com
Core merchandise of TRxADE HEALTH

This indicator captures the total value of corporate resources, calculated inversely via return on assets (ROA) to verify business scale and listing compliance. By analyzing the asset trajectory through ROA, investors determine capital management efficiency, which for the IT platform TRxADE HEALTH (MEDS) reflects its ability to digitize the pharmaceutical sector while maintaining technological superiority through flexible resource management and human capital potential.

Key competitors

VEEV - Company Total Asset Base|DOCS (Doximity) - Company Total Assets|HealthEquity Inc (HQY) - Company Total Asset Base|Cumulative Company Assets WAY (Waystar Inc.)|Aggregate Business Assets CRVL|Privia Health Group - Cumulative Company Assets|Aggregate Asset Value HURN|CERT - Aggregate Company Assets|Omnicell Inc (OMCL) - Cumulative Company Assets|GDRX: Company Total Assets|Company Assets Schrodinger Corp (SDGR)|PHR (Phreesia, Inc.) - Company Total Assets|Total Business Assets OMDA (omadahealth.com)|Cumulative Company Assets EVH (Evolent Health)|Aggregate Business Assets HSTM|Aggregate Company Assets Definitive Healthcare Inc. DH|Aggregate Asset Value CCSI|AGL: Cumulative Company Assets|ABSI (absci.com) - Total Business Assets|SY: Company Total Assets|National Research Corp. (NRC) - Company Total Assets|SPOK (Spok Corp) - Company Total Assets|Total Business Assets OPRX (OptimizeRx Inc.)|Company Total Assets TBRG|SLP - Company Assets|SOPHiA GENETICS - Cumulative Company Assets|Aggregate Asset Value HCAT|CareCloud Corp - Company Total Assets|Aggregate Asset Value RSSS (Research Solutions Inc.)|DLHC: Company Total Assets|Company Assets OneMedNet (ONMD)|SCNX (Scienture) - Company Total Assets|Company Total Assets Healthcare Triangle Inc|Aggregate Company Assets iSpecimen Inc. (ISPC)|Aggregate Company Assets BFRG (bullfrogai.com)|SCWorx Corp. - Cumulative Company Assets|Aggregate Business Assets MSPR (msprecovery.com)|iCoreConnect Corp - Company Total Assets|Aggregate Asset Value ORGS (Orgenesis Inc)|RCM (r1rcm.com) - Cumulative Company Assets|Sharecare Inc - Aggregate Asset Value|STRM (Streamline Health Solutions) - Company Total Assets|syrahealth.com (SYRA) - Company Total Asset Base|Aggregate Company Assets Apollo Medical Holdings (AMEH)|Model N Inc - Total Business Assets|Company Total Assets NXGN (NextGen)